T13	Treatment 4 39	tirapazamine-plus-cisplatin regimen
T15	Effect 60 218	mild to moderate adverse events, including acute, reversible hearing loss, reversible, intermittent muscle cramping, diarrhea, skin rash, nausea, and vomiting
T17	Drug 4 16	tirapazamine
T18	Drug 22 31	cisplatin
T14	Adverse_event 44 54	associated
T19	Combination 17 21	plus
E1	Adverse_event:T14 
E2	Combination:T19 arg:T17 arg2:T18